ALS Investment Fund
Venture capital
UncertainLast verified 10 Nov 2026
Venture capital fund investing in biotech companies developing drugs for neurodegenerative diseases, with a primary focus on ALS.
0 deals in the last 24 months, latest 13 Nov 2023. Taken from its own website.
Key facts
- Sectors
- Biotech & pharma
- Eligible countries
- Not stated
- Provider based in
- Netherlands
- Timing
- Rolling applications
- Focus
- biotech drug development; neurodegeneration; ALS therapies
- How to apply
- Apply route unknown
Recent deals
No deals in our data for the last 24 months.
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Kind
We are a Venture Capital fund that invests in biotech companies developing drugs in a specialized area of disease: neurodegeneration, with a particular focus…
https://www.alsinvestmentfund.com/ - Sectors
invests in biotech companies developing drugs in a specialized area of disease: neurodegeneration
https://www.alsinvestmentfund.com/
Status history
- 10 Nov 2026: Rolling → Uncertain (freshness: investor activity)
- 6 Nov 2026: Rolling (first extraction)
Is something out of date?
Suggest an editTakes 10 seconds
Something else wrong? Report an error.
Work at ALS Investment Fund? Claim this profile to confirm what you invest in.